ADC TOXICITY ATLAS
Payloads & linkers
Payload · Taxane

Paclitaxel

Microtubule stabilizer / tubulin inhibitor (antimitotic)

CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
Physicochemistry

Properties

MW
853.9 Da
XLogP3
2.5
logD₇.₄
-
TPSA
221 Ų
pKa
-
Charge pH 7.4
0
H-bond donors
4
H-bond acceptors
14
Bystander
-
PubChem CID
36314
Bioactivity
Payload paclitaxel: microtubule-stabilizing taxane (binds beta-tubulin, blocks microtubule depolymerization; ADCdb therapeutic target Microtubule PATR0CXRBX). Bevacizumab binds/neutralizes VEGF-A. No discrete IC50/binding affinity values reported on the ADCdb AB-160 page. Phase I
1 agent

ADCs built on this payload

Agent · target
Ocular
Hepatic
Neutrop.
Thrombo.
Anemia
GI
ILD
Neuro.
AB-160VEGFA
10
30
90
30
100
100
10
90
0%severity100%
0
Assessed · clear
true 0%
No data
never assessed